We are live on ! Find out more
Qube Research & Technologies (QRT)

Qube Research & Technologies (QRT) Portfolio holdings

AUM $89.9B
1-Year Est. Return 20.22%
This Fund
S&P 500
This Quarter Est. Return
-4.58%
1 Year Est. Return
+20.22%
3 Year Est. Return
+42.42%
5 Year Est. Return
+23.97%
10 Year Est. Return
–
AUM
$38.3B
AUM Growth
+$10.8B
Cap. Flow
+$12.9B
Cap. Flow %
33.6%
Top 10 Hldgs %
9.4%
Holding
4,435
New
2,018
Increased
1,007
Reduced
916
Closed
371

Top Buys

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$302M
2
ADBE icon
Adobe
ADBE
+$291M
3
AMZN icon
Amazon
AMZN
+$266M
4
MSFT icon
Microsoft
MSFT
+$257M
5
LLY icon
Eli Lilly
LLY
+$214M

Top Sells

Rank Stock Value
1
GOOG icon
Alphabet (Google) Class C
GOOG
+$192M
2
CB icon
Chubb
CB
+$160M
3
AMD icon
Advanced Micro Devices
AMD
+$144M
4
DIS icon
Walt Disney
DIS
+$134M
5
CVS icon
CVS Health
CVS
+$132M

Sector Composition

Rank Sector Weight
1 Technology 19.59%
2 Consumer Discretionary 12.46%
3 Financials 10.63%
4 Industrials 10.62%
5 Healthcare 10.25%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LSF icon
3976
Laird Superfood
LSF
$45.9M
$4 ﹤0.01%
+4
New +$4
LVO icon
3977
LiveOne
LVO
$65.6M
– –
0
– –
PYXS icon
3978
Pyxis Oncology
PYXS
$187M
$4 ﹤0.01%
+2
New +$5
RPID icon
3979
Rapid Micro Biosystems
RPID
$99.1M
$4 ﹤0.01%
+4
New +$4
WNW icon
3980
Meiwu Technology Co
WNW
$3.38M
– –
0
– –
VINC
3981
DELISTED
Vincerx Pharma, Inc. Common Stock
VINC
– –
0
– –
RVLP
3982
DELISTED
RVL Pharmaceuticals plc Ordinary Shares
RVLP
$4 ﹤0.01%
+50
New +$14
SDIG
3983
DELISTED
Stronghold Digital Mining, Inc. Class A Common Stock
SDIG
$4 ﹤0.01%
+1
New +$6
CALC icon
3984
CalciMedica
CALC
$11.3M
$3 ﹤0.01%
+1
New +$3
CLSD
3985
DELISTED
Clearside Biomedical
CLSD
– –
0
– –
CVM icon
3986
CEL-SCI Corp
CVM
$20.6M
– –
0
– –
CYN icon
3987
Cyngn
CYN
$15.9M
– –
0
– –
GP
3988
GreenPower Motor Co
GP
$10.6M
– –
0
– –
INDP icon
3989
Indaptus Therapeutics
INDP
$300M
– –
0
– –
IMDX
3990
Insight Molecular Diagnostics
IMDX
$153M
$3 ﹤0.01%
+1
New +$4
PASG icon
3991
Passage Bio
PASG
$15.4M
– –
0
– –
RZLT icon
3992
Rezolute
RZLT
$473M
$3 ﹤0.01%
+2
New +$3
SLDB icon
3993
Solid Biosciences
SLDB
$788M
$3 ﹤0.01%
+1
New +$4
SLS icon
3994
SELLAS Life Sciences
SLS
$2.24B
$3 ﹤0.01%
+2
New +$3
FTH
3995
Faeth Therapeutics
FTH
$767M
– –
0
– –
SOHO
3996
DELISTED
Sotherly Hotels
SOHO
$3 ﹤0.01%
+2
New +$4
TARA icon
3997
Protara Therapeutics
TARA
$228M
$3 ﹤0.01%
+2
New +$5
VTAK icon
3998
Catheter Precision
VTAK
$967K
– –
0
– –
FUV
3999
DELISTED
Arcimoto, Inc. Common Stock
FUV
$3 ﹤0.01%
+4
New +$5
MARK
4000
DELISTED
Remark Holdings, Inc.
MARK
$3 ﹤0.01%
+7
New +$5
158 159
160
161 162

Similar funds

Focus Partners Wealth
Focus Partners Wealth Boston, Massachusetts $89.9B AUM 20.5% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $92.9B AUM 36.98% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return
Cetera Investment Advisers
Cetera Investment Advisers Schaumburg, Illinois $94B AUM 20.14% 1-Year Est. Return
Mariner
Mariner Overland Park, Kansas $85.7B AUM 24.21% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
California State Teachers Retirement System (CalSTRS)
California State Teachers Retirement System (CalSTRS) West Sacramento, California $94.5B AUM 29.33% 1-Year Est. Return

Qube Research & Technologies (QRT)'s Q3 2023 Portfolio in Review

As of Q3 2023, Qube Research & Technologies (QRT) held 4,435 positions worth $38.3B, up 39% from $27.5B the previous quarter. Its ten largest holdings account for 9.4% of the portfolio.

Qube Research & Technologies (QRT) deployed $12.9B of net new capital in Q3 2023, opening 2,018 new positions and adding to 1,007 existing holdings. Its largest new stake was Eli Lilly: 415,473 shares worth $223M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 21% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was Alphabet (Google) Class C, an estimated $192M trimmed.

  • Qube Research & Technologies (QRT)'s largest Q3 2023 buy was Eli Lilly: 415,473 shares worth $223M.
  • Qube Research & Technologies (QRT) added most to Johnson & Johnson in Q3 2023, an estimated $302M increase.
  • Qube Research & Technologies (QRT)'s biggest Q3 2023 reduction was Alphabet (Google) Class C, cutting an estimated $192M.
  • Qube Research & Technologies (QRT) fully exited Walt Disney in Q3 2023, selling an estimated $134M.
  • Qube Research & Technologies (QRT)'s ten largest holdings make up 9.4% of its $38.3B portfolio in Q3 2023.
  • Qube Research & Technologies (QRT) opened 2,018 new positions and closed 371 in Q3 2023.
  • Qube Research & Technologies (QRT)'s portfolio value rose 39% quarter-over-quarter to $38.3B.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q3 2023, filed 13 Nov 2023.